Acute lung injury (ALI) represents a rapid-onset condition in which the lung tissue becomes severely inflamed, leading to impaired gas exchange and respiratory distress. It can result from direct insults, such as pneumonia, aspiration, or inhalation of toxic substances, or indirect causes like sepsis, trauma, or severe pancreatitis. Patients typically present with sudden shortness of breath, rapid breathing, hypoxemia, and diffuse infiltrates visible on imaging studies. Early recognition is critical, as untreated ALI can progress to acute respiratory distress syndrome (ARDS), a more severe form with high morbidity and mortality. Diagnosis relies on clinical evaluation, arterial blood gas analysis, chest imaging, and the exclusion of cardiac causes of pulmonary edema.
Management of acute lung injury involves a combination of supportive care and targeted interventions to minimize lung damage. Oxygen supplementation and non-invasive or invasive mechanical ventilation are often required to maintain adequate oxygenation. Strategies such as low tidal volume ventilation, prone positioning, and careful fluid management help reduce ventilator-induced injury and improve gas exchange. Treating the underlying cause—whether infection, trauma, or systemic inflammation—is essential to halt progression. Adjunctive therapies may include sedation, anticoagulation, or specific pharmacologic agents depending on the clinical scenario. Multidisciplinary teams, including pulmonologists, critical care specialists, and respiratory therapists, collaborate to optimize care, monitor complications, and support recovery. Early intervention and comprehensive management of acute lung injury can improve survival, reduce long-term respiratory impairment, and enhance overall patient outcomes.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation